William J. Febbo

William J. Febbo

DirectoratOptimizeRx· In proxies 2022–2025

Pay in FY2023+302% from the year before · OptimizeRx stock -14.8% the same year

William J. Febbo was paid $2.8M in FY2023 (Dec), up 302%. OptimizeRx stock fell 14.8% that year.

Pay$100 in the stock at the end of FY21 → $23
Pay is from the Summary Compensation Table of each OptimizeRx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. LifeMDPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. OptimizeRxPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -85%
  3. Performance Health SystemsPublic company
    • Director? – PresentNo stock prices for these years
  4. United Nations of Greater BostonPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?